EFPIA Warns of Fake Jabs If Vaccine Patents Are Waived

The transcript discusses the inequality in global vaccine distribution, highlighting that wealthier regions have received a disproportionate share of vaccines. The main bottleneck is manufacturing capacity, not IP protection. Efforts are being made to increase production through technology transfer and partnerships. Political pressure is unnecessary as companies are already motivated to ramp up production. The EU has donated many doses, and other regions are encouraged to do the same.

What percentage of the world's population do the wealthiest 27 places account for, and what percentage of vaccinations have they received?

• 5% of the population and 20% of vaccinations

• 15% of the population and 40% of vaccinations

• 27% of the population and 50% of vaccinations

• 10.5% of the population and 35.6% of vaccinations

What is identified as the main bottleneck in increasing COVID-19 vaccine production?

• Insufficient funding

• Lack of raw materials

• Manufacturing capacity

• IP protection rules

Why is simply removing IP protections for vaccines not a straightforward solution?

• It would eliminate the need for technology transfer

• It could cause quality control issues and raw material diversion

• It would lead to an immediate increase in production

• It would make vaccines cheaper for all countries

What is the role of voluntary licenses in the context of vaccine production?

• They are mandatory for all vaccine manufacturers

• They facilitate partnerships between companies to ensure quality production

• They allow any company to produce vaccines without oversight

• They are only used in developed countries

What stance is the European Commission taking regarding vaccine distribution?

• They are withholding vaccines for their own population

• They are considering measures to increase manufacturing

• They are against any form of international cooperation

• They are focusing solely on IP protection removal

What is the suggested immediate action to address vaccine distribution inequality?

• Stop all voluntary licensing agreements

• Focus solely on developing new vaccines

• Redistribute excess doses from countries with surplus

• Increase IP protection for vaccines

What is the main reason for the urgency in getting vaccines distributed globally?

• To reduce the cost of vaccines

• To prevent the creation of new virus variants

• To eliminate the need for technology transfer

• To increase the profits of pharmaceutical companies